Alopecia Leukopak

LeukoCore Alopecia Leukopak for Immunology Research

LeukoCore Alopecia Leukopak biospecimens are collected from donors clinically diagnosed with Alopecia through IRB-approved apheresis procedures. Each leukopak contains large quantities of peripheral blood mononuclear cells (PBMCs), making it ideal for immune profiling, cytokine analysis, and drug development research related to Alopecia-associated inflammation and immune dysregulation.

Product Features

  • Research Use Only (RUO) human leukopaks
  • Clinically confirmed Alopecia donors
  • High cell yield for large-scale studies
  • Processed and shipped within 24 hours of collection
  • Fresh or cryopreserved options available
  • IRB-approved and ethically sourced
  • Infectious disease testing
  • HLA-A typing
  • Screen donors with LeukoLot™

De-identified Donor Data

  • Verified Alopecia diagnosis from healthcare providers
  • Donor demographics: age, sex assigned at birth, race/ethnicity
  • Self-reported medication history and allergies
  • Relevant clinical data Alopecia

Applications

  • Immune cell characterization in Alopecia
  • Therapeutic development and screening
  • Cell-based assays and cytokine profiling
  • Multi-omics studies single-cell sequencing

Compliance and Quality Assurance

  • Collected under IRB oversight with donor e-consent (21 CFR Part 11 compliant)
  • HIPAA-compliant handling of donor information
  • Rigorous donor screening and documentation

Ordering & Customization

Alopecia Leukopak samples are available fresh or cryopreserved. Need a different condition, or want to check current availability across our full leukopak inventory? Visit our human leukopak page to browse other disease-state options and live stock status. For international shipping or regulatory documentation, please contact learnmore@sanguinebio.com to confirm regional compliance and shipping availability.

Protocols & Documentation

  • Leukopak Cryopreservation

    Standard operating procedure for cryopreserving leukopak units with controlled freezing and post-thaw viability targets.

    Download
  • Leukopak Thawing

    Validated thawing workflow for cryopreserved leukopaks to maximize recovery while maintaining sterility and chain of custody.

    Download
  • Choosing the Right PBMC Configuration

    Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

Leukopak

Frequently Asked Questions

×

Ask a Question

Need a custom Leukopak cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information